(Q38140046)

29 August 2017

MicroRNAs and multiple sclerosis: from physiopathology toward therapy (English)

1 reference

29 August 2017

0 references

1 reference

3

1 reference

29 August 2017

Yves Renaudineau

2

0 references

author name string

Ameneh Zare-Shahabadi

series ordinal

1

1 reference

PubMed ID

24053428

29 August 2017

language of work or name

English

0 references

publication date

21 September 2013

1 reference

Expert Opinion on Therapeutic Targets

29 August 2017

1 reference

29 August 2017

17

1 reference

29 August 2017

1497-1507

1 reference

29 August 2017

12

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.838219

29 August 2017

1 reference

Pathophysiology of translational regulation by microRNAs in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.838219

Selective miRNA disruption in T reg cells leads to uncontrolled autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.838219

Alterations of the microRNA network cause neurodegenerative disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.838219

Next-generation sequencing of small RNAs from HIV-infected cells identifies phased microrna expression patterns and candidate novel microRNAs differentially expressed upon infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.838219

Differential micro RNA expression in PBMC from multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.838219

MicroRNA, a new paradigm for understanding immunoregulation, inflammation, and autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.838219

Altered microRNA expression in B lymphocytes in multiple sclerosis: towards a better understanding of treatment effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.838219

MicroRNAs in multiple sclerosis and experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.838219

Epigenetics and miRNAs in the diagnosis and treatment of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.838219

The estrogen receptor-alpha-induced microRNA signature regulates itself and its transcriptional response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.838219

Specification and maintenance of oligodendrocyte precursor cells from neural progenitor cells: involvement of microRNA-7a

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.838219

MicroRNA patents in demyelinating diseases: a new diagnostic and therapeutic perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.838219

Mediators of oligodendrocyte differentiation during remyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.838219

Dicer1 and miR-219 Are required for normal oligodendrocyte differentiation and myelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.838219

Altered expression of miR-17-5p in CD4+ lymphocytes of relapsing-remitting multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.838219

Control of oligodendroglial cell number by the miR-17-92 cluster

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.838219

MicroRNAs: novel regulators of oligodendrocyte differentiation and potential therapeutic targets in demyelination-related diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.838219

MicroRNAs are universal regulators of differentiation, activation, and polarization of microglia and macrophages in normal and diseased CNS

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.838219

Heterogeneity of CNS myeloid cells and their roles in neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.838219

Polarization profiles of human M-CSF-generated macrophages and comparison of M1-markers in classically activated macrophages from GM-CSF and M-CSF origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.838219

MicroRNA-124 promotes microglia quiescence and suppresses EAE by deactivating macrophages via the C/EBP-α-PU.1 pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.838219

CCAAT-enhancer binding protein alpha is expressed in activated microglial cells after brain injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.838219

NeurimmiRs: microRNAs in the neuroimmune interface.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.838219

The astrocyte in multiple sclerosis revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.838219

MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.838219

CD4 T cells: fates, functions, and faults

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.838219

Diversity of T cell receptor alpha and beta chain genes expressed by human T cells specific for similar myelin basic protein peptide/major histocompatibility complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.838219

Decreased dependence of myelin basic protein-reactive T cells on CD28-mediated costimulation in multiple sclerosis patients. A marker of activated/memory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.838219

T cells responsive to myelin basic protein in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.838219

MicroRNA let-7e is associated with the pathogenesis of experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.838219

MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.838219

MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.838219

MicroRNAs miR-17 and miR-20a inhibit T cell activation genes and are under-expressed in MS whole blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.838219

Altered miRNA expression in T regulatory cells in course of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.838219

miR-29ab1 deficiency identifies a negative feedback loop controlling Th1 bias that is dysregulated in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.838219

Micro-RNA dysregulation in multiple sclerosis favours pro-inflammatory T-cell-mediated autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.838219

IL-17A secretion by CD8+ T cells supports Th17-mediated autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.838219

Role of CD8 T cell subsets in the pathogenesis of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.838219

Pathogenic CD8 T cells in multiple sclerosis and its experimental models

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.838219

Multiple sclerosis immunology: The healthy immune system vs the MS immune system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.838219

Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.838219

The evidence for a role of B cells in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.838219

Role of microRNA-155 in autoimmunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.838219

Inositol phosphatase SHIP1 is a primary target of miR-155

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.838219

Circulating microRNAs: a novel class of potential biomarkers for diagnosing and prognosing central nervous system diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.838219

miR-15a and 16-1 are downregulated in CD4+ T cells of multiple sclerosis relapsing patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.838219

MicroRNA-128 inhibits glioma cells proliferation by targeting transcription factor E2F3a

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.838219

Circulating microRNAs involved in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.838219

Expression and Genetic Analysis of MicroRNAs Involved in Multiple Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.838219

B-cell subsets up-regulate α4 integrin and accumulate in the cerebrospinal fluid in clinically isolated syndrome suggestive of multiple sclerosis onset.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.838219

Glatiramer acetate treatment normalizes deregulated microRNA expression in relapsing remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.838219

MicroRNA expression changes during interferon-beta treatment in the peripheral blood of multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.838219

Impaired neurosteroid synthesis in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.838219

Circulating microRNAs as biomarkers for disease staging in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.838219

Silencing microRNA-155 ameliorates experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.838219

MicroRNAs as active players in the pathogenesis of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.838219

Many commonly used siRNAs risk off-target activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.838219

Role of microRNAs in plant and animal development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.838219

Rational design of therapeutic siRNAs: minimizing off-targeting potential to improve the safety of RNAi therapy for Huntington's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.838219

Asymmetric siRNA: new strategy to improve specificity and reduce off-target gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.838219

Inhibition of microRNA function by antimiR oligonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.838219

MicroRNAs in neuronal function and dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.838219

Developing drugs that can cross the blood-brain barrier: applications to Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.838219

10.1517/14728222.2013.838219

21 January 2018

Identifiers

DOI

1 reference

29 August 2017

1 reference

PubMed ID

24053428